Showing 1–28 of 28 results
-
-
Research |
-
-
Research |
Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy
- J Gauthier
- , L Castagna
- , F Garnier
- , T Guillaume
- , G Socié
- , S Maury
- , N Maillard
- , R Tabrizi
- , T Marchand
- , J Malfuson
- , A Gac
- , E Gyan
- , M Mercier
- , Y Béguin
- , J Delage
- , P Turlure
- , A Marçais
- , S Nguyen
- , R Dulery
- , J Bay
- , A Huynh
- , E Daguindau
- , J Cornillon
- , C Régny
- , M Michallet
- , R Peffault de Latour
- , I Yakoub-Agha
- & D Blaise
Bone Marrow Transplantation 52 , 689–696 -
-
Impact of pre-transplant diffusion lung capacity for nitric oxide (DLNO) and of DLNO/pre-transplant diffusion lung capacity for carbon monoxide (DLNO/DLCO) ratio on pulmonary outcomes in adults receiving allogeneic stem cell transplantation for hematological diseases
- A Le Bourgeois
- , F Malard
- , P Chevallier
- , G Urbistandoy
- , T Guillaume
- , J Delaunay
- , P Peterlin
- , P Lemarchand
- , P Germaud
- , M Mohty
- , P Moreau
- & A Chambellan
Bone Marrow Transplantation 51 , 589–592 -
Research |
-
Research |
-
Research |
-
Research |
-
Research |
-
-
Research |
-
Research |
-
-
Research |
-
Research |
-
Research |
-
Research |
-
Prophylaxis with mycophenolate mofetil and CsA can decrease the incidence of severe acute GVHD after antithymocyte globulin-based reduced-intensity preparative regimen and allo-SCT from HLA-matched unrelated donors
- E Brissot
- , P Chevallier
- , T Guillaume
- , J Delaunay
- , S Ayari
- , V Dubruille
- , S Le Gouill
- , B Mahe
- , T Gastinne
- , N Blin
- , B Saulquin
- , P Moreau
- , J-L Harousseau
- & M Mohty
Bone Marrow Transplantation 45 , 786–788 -
Research |
-
-
Research |
-
Research |
-
-
Research |
-
Protocols |
-
Research |